Company profile
LeMaitre Vascular, Inc.
NASDAQ: LMAT · Healthcare · Medical - Instruments & Supplies
#271 of 1,418 Healthcare companies by revenue59th-percentile growth
EA Score
80B+FH 87DQ 80GM 60SS 82
v0.1 · 65/100 weight · provisional
↑ operating margin, net margin · ↓ growth stability, revenue growth (YoY)
Methodology →Revenue TTM
$256.3M
Rev growth YoY (TTM)
+13.3%
Net income (FY)
$57.7M
Employees
655
as of 2026-08-09
Market cap
$1.9B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$249.6M$249.6M2025
Net income$57.7M$57.7M2025
Operating income$67.9M$67.9M2025
Total assets$615.7M$615.7M2025
Liabilities$222.2M$222.2M2025
Equity$393.5M$393.5M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY23
FY23
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is LeMaitre Vascular, Inc.’s revenue?
LeMaitre Vascular, Inc. booked $249.6M in FY2025 revenue, growing 14% year over year — about the middle of the pack among Healthcare companies we track, at a 23.1% net margin.
Peers · Healthcare
Omada Health62CMedical Facilities Corporation74BFrontage Holdings Corporation72BAmerican Well Corporation60CMesa Laboratories, Inc.78B+Keros Therapeutics, Inc.71BNeighbors
Middlesex →Key facts
CEOGeorge W. LeMaitre
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBurlington, MA
ExchangeNASDAQ: LMAT
Employees655
IPO date2006-10-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.